SCHEMBL4421067

SCHEMBL4421067

CCCCCCCCCCCCCCCCOC(=O)C(=Cc1ccccc1)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
ALDH1A1 P00352 3/20 0.50
TSHR P16473 2/20 0.50
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPK1 P28482 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
POLB P06746 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PPARG P37231 3/20 0.44
EGFR P00533 1/20 0.44
FAAH O00519 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15610 1.00 LMNA (0.50) LMNAALDH1A1TSHRTP53CYP3A4
SCHEMBL4629242 1.00 LMNA (0.50) LMNAALDH1A1TSHRTP53CYP3A4
SCHEMBL6674757 1.00 LMNA (0.50) LMNAALDH1A1TSHRTP53CYP3A4
SCHEMBL8872228 1.00 LMNA (0.50) LMNAALDH1A1TSHRTP53CYP3A4
SCHEMBL8872482 1.00 LMNA (0.50) LMNAALDH1A1TSHRTP53CYP3A4
SCHEMBL3460324 0.99 TSHR (0.49) LMNAALDH1A1TSHRTP53CYP3A4
Acetic Acid SCHEMBL28691928 0.97 TSHR (0.48) LMNAALDH1A1TSHRTP53CYP3A4
Alcohol SCHEMBL27701846 0.97 LMNA (0.48) LMNAALDH1A1TSHRTP53CYP3A4
Glycolic Acid SCHEMBL3845223 0.95 LMNA (0.46) LMNAALDH1A1TSHRTP53CYP3A4
SCHEMBL29696492 0.95 TDP1 (0.46) LMNAALDH1A1TSHRTP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370657-B2 Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene CURNA, INC. (US) 2019-08-06 US disclosed
US-20170073680-A1 TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE CURNA, INC. 2017-03-16 US disclosed
EP-1187598-B1 MICROPIGMENT MIXTURE BASF SE (DE) 2009-10-21 EP disclosed